Cargando…

NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases

Nociceptin/orphanin FQ (N/OFQ) is a seventeen-amino acid peptide that is the endogenous ligand of a G-protein-coupled receptor (NOP). Various immune cells express the precursor protein and secrete N/OFQ as well as display binding sites for this peptide. The functional capacity of NOP receptor was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavioli, Elaine C., Romão, Pedro R. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268226/
https://www.ncbi.nlm.nih.gov/pubmed/22312472
http://dx.doi.org/10.4061/2011/836569
_version_ 1782222365698031616
author Gavioli, Elaine C.
Romão, Pedro R. T.
author_facet Gavioli, Elaine C.
Romão, Pedro R. T.
author_sort Gavioli, Elaine C.
collection PubMed
description Nociceptin/orphanin FQ (N/OFQ) is a seventeen-amino acid peptide that is the endogenous ligand of a G-protein-coupled receptor (NOP). Various immune cells express the precursor protein and secrete N/OFQ as well as display binding sites for this peptide. The functional capacity of NOP receptor was demonstrated in vitro and in vivo studies by the ability of N/OFQ to induce chemotaxis of immune cells, to regulate the expression of cytokines and other inflammatory mediators, and to control cellular and humoral immunity. In this context, N/OFQ could modulate the outcome of some inflammatory diseases, such as sepsis and autoimmune pathologies by mechanisms not clearly elucidated yet. In fact, human body fluid revealed increased levels of N/OFQ under sepsis, arthritis, and Parkinson's diagnose. Preclinical studies pointed to the blockade of NOP receptor signaling as successful in treating these experimental conditions. Further preclinical and clinical studies are required to investigate the potential of NOP ligands in treating inflammatory diseases.
format Online
Article
Text
id pubmed-3268226
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-32682262012-02-06 NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases Gavioli, Elaine C. Romão, Pedro R. T. J Amino Acids Review Article Nociceptin/orphanin FQ (N/OFQ) is a seventeen-amino acid peptide that is the endogenous ligand of a G-protein-coupled receptor (NOP). Various immune cells express the precursor protein and secrete N/OFQ as well as display binding sites for this peptide. The functional capacity of NOP receptor was demonstrated in vitro and in vivo studies by the ability of N/OFQ to induce chemotaxis of immune cells, to regulate the expression of cytokines and other inflammatory mediators, and to control cellular and humoral immunity. In this context, N/OFQ could modulate the outcome of some inflammatory diseases, such as sepsis and autoimmune pathologies by mechanisms not clearly elucidated yet. In fact, human body fluid revealed increased levels of N/OFQ under sepsis, arthritis, and Parkinson's diagnose. Preclinical studies pointed to the blockade of NOP receptor signaling as successful in treating these experimental conditions. Further preclinical and clinical studies are required to investigate the potential of NOP ligands in treating inflammatory diseases. SAGE-Hindawi Access to Research 2011 2011-11-17 /pmc/articles/PMC3268226/ /pubmed/22312472 http://dx.doi.org/10.4061/2011/836569 Text en Copyright © 2011 E. C. Gavioli and P. R. T. Romão. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gavioli, Elaine C.
Romão, Pedro R. T.
NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
title NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
title_full NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
title_fullStr NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
title_full_unstemmed NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
title_short NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases
title_sort nop receptor ligands as potential agents for inflammatory and autoimmune diseases
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268226/
https://www.ncbi.nlm.nih.gov/pubmed/22312472
http://dx.doi.org/10.4061/2011/836569
work_keys_str_mv AT gaviolielainec nopreceptorligandsaspotentialagentsforinflammatoryandautoimmunediseases
AT romaopedrort nopreceptorligandsaspotentialagentsforinflammatoryandautoimmunediseases